SA PRO
Free Account
Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
10 analysts·Moderate coverage
100%
Rating Distribution
Strong Buy
00%
Buy
10100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 23% higher.

Bear Case
$50.00
+17%
Consensus
$52.50
+23%
Bull Case
$55.00
+29%
Price Range10 analysts
Low
Consensus
High
$50.00
$55.00
Current Target
Current Price
$42.58
Upside to Target
$9.92

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 13, 2026Wedbush
Kiniksa price target raised to $50 from $48 at Wedbush
Target:$50.00
+26.1%from $39.65
Oct 29, 2025Goldman Sachs
Kiniksa price target raised to $55 from $45 at Goldman Sachs
Target:$55.00
+45.5%from $37.81
Oct 13, 2025Wedbush
Kiniksa price target raised to $44 from $38 at Wedbush
Target:$44.00
+16.1%from $37.89
Jul 29, 2025Jefferies
Kiniksa price target raised to $54 from $45 at Jefferies
Target:$54.00
+77.8%from $30.37
Oct 29, 2024Evercore ISI
Kiniksa (KNSA) PT Raised to $35 at Evercore ISI
Target:$35.00
+50.4%from $23.27
Sep 13, 2024Jefferies
Jefferies Starts Kiniksa (KNSA) at Buy
Target:$40.00
+63.3%from $24.49
May 3, 2024Wells Fargo
Wells Fargo Starts Kiniksa (KNSA) at Overweight, 'we see +15-25% upside potential'
Target:$34.00
+75.4%from $19.38

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance